Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 6CM3 | P01730 | BG505 SOSIP in complex with sCD4, 17b, 8ANC195 | Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain |
| 6CM3 | 6CM3 | BG505 SOSIP in complex with sCD4, 17b, 8ANC195 | Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain |
| 7L7T | 7L7T | BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component A) | |
| 7L7U | 7L7U | BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component B) | |
| 6VL5 | 6VL5 | BG505 SOSIP reconstructed from a designed tetrahedral nanoparticle, BG505 SOSIP-T33_dn2 | |
| 6V0R | Q2N0S6 | BG505 SOSIP.664 Trimer | |
| 5VIY | Q2N0S6 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | P01834 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | P01834 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | 5VIY | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | S6B291 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | S6B291 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 5VIY | Q8TCD0 | BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 | |
| 7KDE | Q2N0S6 | BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 interface antibody 8ANC195 | |
| 7KDE | 7KDE | BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 interface antibody 8ANC195 | |
| 5V8L | Q2N0S6 | BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145 | |
| 5V8L | 5V8L | BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145 | |
| 5V8M | Q2N0S6 | BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibody 3BNC117 | |
| 5V8M | 5V8M | BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibody 3BNC117 | |
| 6OZC | Q2N0S6 | BG505 SOSIP.664 with 2G12 Fab2 | |
| 6OZC | 6OZC | BG505 SOSIP.664 with 2G12 Fab2 | |
| 6VN0 | Q2N0S6 | BG505 SOSIP.v4.1 in complex with rhesus macaque Fab RM20F | |
| 6VN0 | 6VN0 | BG505 SOSIP.v4.1 in complex with rhesus macaque Fab RM20F | |
| 7L8T | 7L8T | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-1 from animal Rh.33311 (Wk26 time point) | |
| 7L8U | 7L8U | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-2 from animal Rh.33311 (Wk26 time point) | |
| 7L8W | 7L8W | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-3 from animal Rh.33311 (Wk26 time point) | |
| 7L8X | 7L8X | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-4 from animal Rh.33311 (Wk26 time point) | |
| 7L8Y | 7L8Y | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-5 from animal Rh.33311 (Wk26 time point) | |
| 7L8Z | 7L8Z | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-7 from animal Rh.33311 (Wk26 time point) | |
| 7L90 | 7L90 | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-8 from animal Rh.33311 (Wk26 time point) | |
| 7LG6 | Q2N0S6 | BG505 SOSIP.v5.2 in complex with VRC40.01 and RM19R Fabs | |
| 7LG6 | 7LG6 | BG505 SOSIP.v5.2 in complex with VRC40.01 and RM19R Fabs | |
| 6VO0 | Q2N0S6 | BG505 SOSIP.v5.2 in complex with rabbit Fab 43A2 | |
| 6VO0 | 6VO0 | BG505 SOSIP.v5.2 in complex with rabbit Fab 43A2 | |
| 6VLR | Q2N0S6 | BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20E1 and PGT122 Fab | |
| 6VLR | 6VLR | BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20E1 and PGT122 Fab | |
| 6VO1 | Q2N0S6 | BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20J | |
| 6VO1 | 6VO1 | BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20J | |
| 7MDT | Q2N0S6 | BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment) | |
| 7MDT | 7MDT | BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment) | |
| 7MEP | 7MEP | BG505 SOSIP.v5.2(7S) in complex with the monoclonal antibodies Rh.33172 mAb.1 and RM19R | |
| 7L8E | Q2N0S5 | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-1 from animal Rh.33172 (Wk38 time point) | |
| 7L8E | 7L8E | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-1 from animal Rh.33172 (Wk38 time point) | |
| 7L8F | Q2N0S5 | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time point) | |
| 7L8F | 7L8F | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time point) | |
| 7L8G | Q2N0S5 | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-3 from animal Rh.33172 (Wk38 time point) | |
| 7L8G | 7L8G | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-3 from animal Rh.33172 (Wk38 time point) | |
| 7L8S | 7L8S | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-4 from animal Rh.33172 (Wk38 time point) |
